scholarly article | Q13442814 |
P50 | author | Andrew James McMichael | Q21165187 |
John R. Mascola | Q63302442 | ||
Assan Jaye | Q71276260 | ||
Christof Geldmacher | Q72530483 | ||
Richard A Koup | Q97635775 | ||
Hilton C. Whittle | Q117235208 | ||
Sarah Rowland-Jones | Q30004285 | ||
P2093 | author name string | Karin Loré | |
Hetty Blaak | |||
William C Adams | |||
Melody G Duvall | |||
Kathlyn Santos | |||
David A Ambrozak | |||
P2860 | cites work | The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | Q24305266 |
Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission | Q24537674 | ||
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor | Q24547409 | ||
CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia | Q24557545 | ||
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins | Q24564187 | ||
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | Q28179446 | ||
DNA deamination mediates innate immunity to retroviral infection | Q28179534 | ||
Hypermutation of HIV-1 DNA in the Absence of the Vif Protein | Q28204475 | ||
HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability | Q28207304 | ||
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex | Q28210666 | ||
Reduced rate of disease development after HIV-2 infection as compared to HIV-1 | Q28237927 | ||
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure | Q28283258 | ||
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses | Q28616569 | ||
The epidemiology of HIV infection in a rural area of Guinea-Bissau. | Q39410257 | ||
Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus | Q39603628 | ||
Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells | Q39616950 | ||
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection | Q39621505 | ||
Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells | Q39684486 | ||
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells | Q40311580 | ||
Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles | Q40378098 | ||
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells | Q40435387 | ||
Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines | Q40485825 | ||
Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation | Q40485830 | ||
Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. | Q40671577 | ||
HIV: dendritic cells as embers for the infectious fire | Q41102414 | ||
Dendrite cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV. | Q41103198 | ||
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. | Q43709144 | ||
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. | Q44664018 | ||
Human immunodeficiency virus types 1 and 2 have different replication kinetics in human primary macrophage culture. | Q45420512 | ||
HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes | Q45623890 | ||
Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells | Q45751781 | ||
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay | Q45766845 | ||
Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells | Q45874802 | ||
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. | Q46175297 | ||
HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. | Q47255292 | ||
Recruitment of HIV and its receptors to dendritic cell-T cell junctions | Q47563778 | ||
Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. | Q51157214 | ||
Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. | Q51186094 | ||
Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. | Q51982441 | ||
Expansion of activated human naïve T-cells precedes effector function. | Q52009198 | ||
HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. | Q55242482 | ||
In vitro replication capacity of HIV-2 variants from long-term aviremic individuals | Q56880140 | ||
Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid | Q70998777 | ||
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 | Q72688559 | ||
Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1 | Q78952566 | ||
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 | ||
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif | Q29618938 | ||
Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). | Q30404166 | ||
Slower heterosexual spread of HIV-2 than HIV-1. | Q30419674 | ||
Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution | Q33180586 | ||
Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. | Q33645462 | ||
Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes | Q33755099 | ||
Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells | Q33806915 | ||
Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells | Q33884007 | ||
HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN | Q34010226 | ||
Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection | Q34270884 | ||
Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. | Q34349213 | ||
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction | Q34390968 | ||
Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo | Q34717597 | ||
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms | Q35168222 | ||
T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis | Q35543827 | ||
Active replication of HIV-1 at the lymphoepithelial surface of the tonsil | Q35763696 | ||
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. | Q35830147 | ||
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. | Q35879177 | ||
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism | Q35896403 | ||
Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge | Q36228649 | ||
Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells | Q36365562 | ||
Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques | Q36366154 | ||
DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells | Q36399522 | ||
Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells | Q36399936 | ||
Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals | Q36637426 | ||
Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia | Q36784415 | ||
Binding of Human Immunodeficiency Virus Type 1 to Immature Dendritic Cells Can Occur Independently of DC-SIGN and Mannose Binding C-Type Lectin Receptors via a Cholesterol-Dependent Pathway | Q37059589 | ||
Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells | Q37730553 | ||
Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses | Q38349570 | ||
Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers | Q38906206 | ||
9-year HIV-2-associated mortality in an urban community in Bissau, west Africa | Q39365679 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
HIV | Q15787 | ||
P304 | page(s) | 13486-13498 | |
P577 | publication date | 2007-10-03 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection | |
P478 | volume | 81 |
Q38752077 | Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated |
Q37845847 | An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine? |
Q36890951 | Biology of HIV mucosal transmission |
Q34035802 | Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis |
Q35677445 | Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells. |
Q38717198 | Engineering broadly neutralizing antibodies for HIV prevention and therapy |
Q40080896 | HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels. |
Q37229398 | HIV interactions with monocytes and dendritic cells: viral latency and reservoirs |
Q37287774 | HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells |
Q41548052 | HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells |
Q42985603 | Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. |
Q27333255 | Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections |
Q30912292 | Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease |
Q37899725 | Myeloid dendritic cells in HIV-1 infection |
Q39448439 | Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers. |
Q55056626 | Restricting HIV the SAMHD1 way: through nucleotide starvation. |
Q42221145 | SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells |
Q39122691 | SAMHD1-dependent retroviral control and escape in mice. |
Q37130458 | Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection. |
Q36690419 | The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals |
Q35115656 | Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes. |
Search more.